Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

1.67
Data as of Jul 11
 0.00 / 0.00%
Today’s Change
1.25
Today|||52-Week Range
3.18
-7.17%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$860.0M

Company Description

Lexicon Pharmaceuticals, Inc. engages in discovery and development of breakthrough treatments for human disease. The company primarily focuses on the discovery of the functions and pharmaceutical utility of genes and the use of those gene function discoveries in the discovery and development of pharmaceutical products for the treatment of human disease. The company uses its proprietary gene knockout technologies and an integrated platform of advanced medical technologies to systematically study the physiological and behavioral functions in mice and assessed the utility of the proteins encoded by the corresponding human genes as potential drug targets. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. Lexicon Pharmaceuticals was founded by Brian P. Zambrowicz and Arthur T. Sands in July 1995 and is headquartered in The Woodlands, TX.

Contact Information

Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands Texas 77381-1160
P:(281) 863-3000
Investor Relations:

Employees

Shareholders

Individual stakeholders65.79%
Other institutional64.66%
Mutual fund holders24.98%

Top Executives

Lonnel CoatsPresident, Chief Executive Officer & Director
John NorthcottVP-Marketing, Commercial Strategy & Operations
Jeffrey L. WadeCFO & Executive VP-Corporate Development
Brian P. ZambrowiczChief Scientific Officer & Executive VP
Alan J. MainExecutive Vice President-Pharmaceutical Research

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.